Cipher Pharmaceuticals starts launch of new acne drug in U.S.
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne
Writer & Business Reporter
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne